Immuno-oncology

RSS

Medarex receives milestone payment from Merck KGaA

Sep. 2, 1998

No Comments

Techniclone advancing development of Tumor Necrosis Therapy into phase II

Sep. 2, 1998

No Comments

Pivotal clinical trial data for rituximab published

Aug. 28, 1998

No Comments

Imutec receives patent protection for Virulizin in Canada

Aug. 24, 1998

No Comments

Available from NIH: immunotoxin for the treatment of ovarian cancer and mesotheliomas

Aug. 20, 1998

No Comments

BLP25 cancer vaccine enters phase I testing in patients with NSCLC

Aug. 19, 1998

No Comments

Canadian patent covers Jenner's cancer vaccine

Aug. 13, 1998

No Comments

Avax to begin pivotal trial with M-Vax in melanoma patients

July 31, 1998

No Comments

MabThera now available for non-Hodgkin's lymphoma in the U.K.

July 23, 1998

No Comments

FDA grants second orphan drug designation for ImmTher

July 20, 1998

No Comments